The Impact of Placental Factors on Fetal Intrauterine Growth and in Intrauterine Programming of the Metabolic Syndrome
NCT ID: NCT01883154
Last Updated: 2013-06-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
160 participants
OBSERVATIONAL
2013-09-30
2023-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Randomized Clinical Trial: Expectant Management vs Laser Treatment of Monochorionic Twins With Severe Selective Intrauterine Growth Retardation and Absent or Reverse Diastolic Flow in the Umbilical Artery
NCT01177553
Dyskinesia, Heterotaxy and Congenital Heart Disease
NCT00608556
A Cohort of Maternal Vascular Malperfusion-related FGR (CoMVMFGR)
NCT06104748
Identification Genetic, Immunologic and Microbial Markers of Hirschsprung Associated Enterocolitis in Children With Hirschsprung Disease
NCT02193685
IUGR, Respiratory Muscle Function, and Exercise Capacity in Childhood
NCT03368755
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
IUGR pregnancies
Pregnancies complicated with IUGR. Fetal growth beneath the 10th percentile
No interventions assigned to this group
pregnancies with Gestational Diabetes
Normal glucose levels before 20 weeks, and positive Oral glucose tolerance test
No interventions assigned to this group
Pre Gestational Diabetes
A diagnosis of Diabetes before pregnancy or elevated glucose levels before 20 weeks.
No interventions assigned to this group
IVF pregnancies
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* A diagnosis of Gestational diabetes
* A diagnosis of pre gestational Diabetes
* IVF pregnancy
Exclusion Criteria
* meconium stained amniotic fluid
* A request of the patient for Cord blood retrieval for preservation
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Meir Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Meir medical center
Kfar Saba, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Tal Biron Shental, MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
loe135673ctil
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.